Serum positive cagA in patients with non-ulcer dyspepsia and peptic ulcer disease from two centers in different regions of Turkey

World Journal of Gastroenterology

Volumn 9, Issue 4, 2003, Pages 833-835

  Serin, Ender ^a   Yilmaz, Udur ^b   Künefeci, Ganiye ^a   Özer, Birol ^a   Gümürdülü, Yüksel ^a   Güçlü, Mustafa ^a   Kayaselçuk, Fazilet ^b   Boyaciodlu, Sedat ^b  

^a Bä Kent University   (Turkey)

^b BASKENT UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

CAGA PROTEIN;

ADULT; ANTIBODY BLOOD LEVEL; ARTICLE; ASIA; COMPARATIVE STUDY; CONTROLLED STUDY; DUODENUM ULCER; DYSPEPSIA; ENZYME IMMUNOASSAY; FEMALE; HELICOBACTER PYLORI; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PEPTIC ULCER; PROTEIN BLOOD LEVEL; SEROPREVALENCE; STOMACH EROSION; STOMACH ULCER; TURKEY (REPUBLIC);

EID: 0037624513     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v9.i4.833     Document Type: Article

References (22)

1. Go MF. What are the host factors that place an individual at risk for Helicobacter pylori-associated disease? Gastroenterology 1997; 113 (Suppl 6): S15-S20
2. Kurata JH, Nogawa AN. Meta-analysis of risk factors for peptic ulcer. Nonsteroidal anti-inflammatory drugs, Helicobacter pylori and smoking. J Clin Gastroenterol 1997; 24: 2-17
3. Atherton JC. The clinical relevance of strain types of Helicobacter pylori. Gut 1997; 40: 701-703
4. Warburton VJ, Everett S, Mapstone NP, Axon AT, Hawkey P, Dixon MF. Clinical and histological associations of cagA and vacA genotypes in Helicobacter pylori gastritis. J Clin Pathol 1998; 51: 55-61
5. Jenks PJ, Megraud F, Labigne A. Clinical outcome after infection with Helicobacter pylori does not appear to be reliably predicted by the presence of any of the genes of the cag pathogenicity island. Gut 1998; 43: 752-758
6. Hua J, Zheng PY, Yeoh KG, Ho B. The status of the cagA gene does not predict Helicobacter pylori-associated peptic ulcer disease in Singapore. Microbios 2000; 102: 113-120
7. Yang JC, Wang TH, Wang HJ, Kuo CH, Wang JT, Wang W. Genetic analysis of the cytotoxin-associated gene and the vacuolating toxin gene in Helicobacter pylori strains isolated from Taiwanese patients. Am J Gastroenterol 1997; 92: 1316-1321
8. Takata T, Fujimoto S, Anzai K, Shirotani T, Okada M, Sawae Y, Ono J. Analysis of the expression of CagA and VacA and the vacuolating activity in 167 isolates from patients with either peptic ulcers or non-ulcer dyspepsia. Am J Gastroenterol 1998; 93: 30-34
9. Ching CK, Wong BC, Kwok E, Ong L, Covacci A, Lam SK. Prevalence of CagA-bearing Helicobacter pylori strains detected by the anti-CagA assay in patients with peptic ulcer disease and in controls. Am J Gastroenterol 1996; 91: 949-953
10. Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol 1996; 20: 1161-1181
11. Crabtree JE,. Taylor JD, Wyatt JI, Heatley RV, Shallcross TM, Tompkins DS, Rathbone BJ. Mucosal IgA recognition of Helicobacter pylori 120 kDa protein, peptic ulceration, and gastric pathology. Lancet 1991; 338: 332-335
12. Kuipers EJ, Perez-Perez GI, Meuwissen SG, Blaser MJ. Helicobacter pylori and atrophic gastritis: Importance of the cagA status. J Natl Cancer Inst 1995; 33: 28-32
13. Rudi J, Kolb C, Maiwald M, Zuna I, Von Herbay A, Galle PR, Stremmel W. Serum antibodies against Helicobacter pylori proteins VacA and CagA are associated with increased risk for gastric adenocarcinoma. Dig Dis Sci 1997; 42: 1652-1659
14. Asahi M, Azuma T, Ito Y, Suto H, Nagai Y, Tsubokawa M, Tohyama Y, Maeda S, Omata M, Suzuki T, Sasakawa C. Helicobacter pylori cagA protein can be tyrosine phosphorylated in gastric epithelial cells. J Exp Med 2000; 191: 593-602
15. Segal ED, Cha J, Lo J, Falkow S, Tompkins LS. Altered states: Involvement of phosphorylated CagA in the induction of host cellular growth changes by Helicobacter pylori. Proc Natl Acad Sci USA 1999; 96: 14559-14564
16. Crabtree JE, Covacci A, Farmery SM, Xiang Z, Tompkins DS, Perry S, Lindley IJ, Rappuoli R. H. pylori-induced interleukin-8 expression in gastric epithelial cells associated with cagA-positive phenotype. J Clin Pathol 1995; 48: 41-45
17. Sharma SA, Tummuru M, Miller G, Blaser MJ. Interleukin-8 response of gastric epithelial cell lines to Helicobacter pylori stimulation in vitro. Infect Immun 1995; 63: 1681-1687
18. Demirturk L, Ozel AM, Yazgan Y, Solmazgul E, Yildirim S, Gultepe M, Gurbuz AK. CagA status in dyspeptic patients with and without peptic ulcer disease in Turkey: Association with histopathological findings. Helicobacter 2001; 6: 163-168
19. Kim HY, Kim YB, Park CK, Yoo JY, Graham DY. Co-existing gastric cancer and duodenal ulcer disease: Role of Helicobacter pylori infection. Helicobacter 1997; 2: 205-209
20. El-Zimaity HMT, Gutierrez O, Kim JG, Akamatsu T, Gurer IE, Simjee AE, Graham DY. Geographic differences in the distribution of intestinal metaplasia in duodenal ulcer patients. Am J Gastroenterol 2001; 96: 666-672
21. Figura N, Vindigni C, Covacci A, Presenti L, Burroni D, Vernillo R, Banducci T, Roviello F, Marreli D, Biscontri M, Krisrtodhullu S, Gennari C, Vaira D. CagA-positive and -negative H. pylori strains are simultaneously present in the stomach of most patients with non-ulcer dyspepsia: Relevance to histological damage. Gut 1998; 42: 772-778
22. Odenbreit S, Puls J, Sedlmaier B, Gerland E, Fischer W, Haas R. Translocation of Helicobacter pylori CagA into gastric epithelial cells by type IV secretion. Science 2000; 287: 1497-1500